hypopituitarism
Information
- Disease name
- hypopituitarism
- Disease ID
- DOID:9406
- Description
- "A pituitary gland disease characterized by the decreased secretion of one or more of the eight hormones normally produced by the pituitary gland." [url:http\://en.wikipedia.org/wiki/Hypopituitarism]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00027430 | Completed | N/A | Androgen Replacement Therapy in Women With Hypopituitarism | September 2001 | December 2004 |
NCT00080483 | Completed | Phase 2 | Testosterone and Growth Hormone for Bone Loss in Men | March 2004 | September 2010 |
NCT00133354 | Completed | Phase 2/Phase 3 | Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys | November 2001 | August 2010 |
NCT00139945 | Completed | N/A | Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient Patients | October 2005 | March 2007 |
NCT00140413 | Completed | Phase 4 | Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia | December 2004 | February 2014 |
NCT00360074 | Completed | Phase 4 | Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation | February 2004 | April 2007 |
NCT00462475 | Completed | Effect of 5 Years of GH Replacement on Atherosclerosis | January 1996 | December 2006 | |
NCT00490191 | Completed | Phase 4 | Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency | January 1999 | July 2001 |
NCT01009905 | Completed | An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone) | June 24, 2002 | September 30, 2016 | |
NCT01028742 | Completed | Posttraumatic Hypopituitarism - Incidence, Predictors and Test Validity | October 2009 | December 2014 | |
NCT01088399 | Completed | A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults | September 2002 | December 2012 | |
NCT01209416 | Completed | N/A | The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin | June 2012 | October 2015 |
NCT01574859 | Completed | Central Hypothyroidism and Cardiovascular Risk | April 2012 | March 2013 | |
NCT02782208 | Completed | N/A | Lipolytic Effects of GH in Hypopituitary Patients in Vivo | February 10, 2016 | December 22, 2016 |
NCT04902235 | Completed | Phase 4 | Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study) | July 6, 2021 | May 1, 2023 |
NCT05188131 | Completed | Phase 4 | Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium | October 1, 2021 | December 31, 2021 |
NCT05206149 | Completed | Phase 4 | Stimulation Test With Intranasal Glucagon for Corticotroph, Somatotroph and Antidiuretic Axes | October 1, 2021 | December 31, 2021 |
NCT05319301 | Completed | N/A | Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study) | April 1, 2022 | November 1, 2023 |
NCT00507104 | Completed | Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH) | September 2006 | November 2008 | |
NCT00572390 | Completed | N/A | Oestrogen Withdrawal in Hypopituitary Women | January 2001 | February 2002 |
NCT00666068 | Completed | N/A | Effects of Corticotropin Releasing Hormone (CRH) on the Sleep in Patients With Hypopituitarism | February 2008 | December 2008 |
NCT00851942 | Completed | Phase 4 | Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test | September 2008 | January 31, 2013 |
NCT00962559 | Completed | Hypopituitarism After Aneurismal Subarachnoid Hemorrhage | February 2008 | February 2010 | |
NCT01007071 | Completed | Phase 3 | Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency | November 1, 2009 | December 12, 2012 |
NCT06326853 | Not yet recruiting | Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models | July 2024 | December 2026 | |
NCT06014398 | Not yet recruiting | N/A | Improving Survivorship and Health-related Quality of Life in Patients With Primary Brain Tumours | September 1, 2023 | September 1, 2025 |
NCT04897802 | Recruiting | Phase 4 | Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study) | September 13, 2021 | December 31, 2024 |
NCT05990491 | Recruiting | Pituitary Function After Recovery From Septic Shock Among ICU Survivors | August 28, 2023 | August 2025 | |
NCT04121780 | Recruiting | Phase 2 | Growth Hormone Replacement Therapy for Retried Professional Football Players | October 8, 2019 | September 2026 |
NCT00504218 | Terminated | Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients | July 17, 2007 | June 12, 2018 | |
NCT02360046 | Terminated | N/A | The Influence of Different Hydrocortisone Replacement Doses on the Partitioning and Flexibility of Ectopic Lipids in Patients With Corticotropic Hypopituitarism | January 2015 | December 2016 |
NCT01666964 | Unknown status | Hormone Deficiency After Brain Injury During Combat | October 2012 | May 2015 | |
NCT02871986 | Unknown status | Pubertal Induction in Individuals With Hypogonadism | September 2016 | March 2020 | |
NCT03708523 | Unknown status | Next Day Growth Hormone Predicting Pituitary Function After Adenomectomy | November 1, 2018 | September 2019 |
- Disase is a (Disease Ontology)
- DOID:53
- Cross Reference ID (Disease Ontology)
- GARD:2917
- Cross Reference ID (Disease Ontology)
- ICD10CM:E23.0
- Cross Reference ID (Disease Ontology)
- MESH:D007018
- Cross Reference ID (Disease Ontology)
- MIM:221750
- Cross Reference ID (Disease Ontology)
- MIM:262600
- Cross Reference ID (Disease Ontology)
- MIM:262700
- Cross Reference ID (Disease Ontology)
- MIM:613038
- Cross Reference ID (Disease Ontology)
- MIM:613986
- Cross Reference ID (Disease Ontology)
- NCI:C62591
- Cross Reference ID (Disease Ontology)
- ORDO:95494
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:74728003
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0020635
- Exact Synonym (Disease Ontology)
- pituitary hormone deficiency
- Exact Synonym (Disease Ontology)
- Pituitary insufficiency
- Disase Synonym (Disease Ontology)
- Pituitary hypofunction
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0040075
- ICD10 preferred id (Insert disease from ICD10)
- D0003695
- ICD10 class code (Insert disease from ICD10)
- E23.0
- MeSH unique ID (MeSH (Medical Subject Headings))
- D007018